Yize Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Traditional Chinese Medicine Analysis
Papers in
-
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Co-authors
- Hongmei Zhang (7 shared papers)Wenchao Liu (5 shared papers)Siqi Wang (1 shared paper)Yunman Li (1 shared paper)Tao Xi (1 shared paper)Weirong Fang (1 shared paper)Wenyuan Liu (1 shared paper)Yonghao Yu (4 shared papers)
- Journals
- Advanced Healthcare Materials (2 papers)ACS Nano (2 papers)Frontiers in Oncology (2 papers)Cell Reports Medicine (1 paper)Organic & Biomolecular Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Yize Li
41 papers receiving 443 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 121
- Complementary and alternative medicine 60
- Developmental Neuroscience 17
- Neurology 29
- Molecular Biology 205
Countries citing papers authored by Yize Li
This map shows the geographic impact of Yize Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yize Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yize Li more than expected).
Fields of papers citing papers by Yize Li
This network shows the impact of papers produced by Yize Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yize Li. The network helps show where Yize Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yize Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 84 | |
| 2 | LPS induces HUVEC angiogenesis in vitro through miR-146a-mediated TGF-β1 inhibition. | 2017 | 35 |
| 3 | 2018 | 30 | |
| 4 | 2014 | 26 | |
| 5 | 2021 | 25 | |
| 6 | 2016 | 24 | |
| 7 | 2022 | 21 | |
| 8 | 2024 | 18 | |
| 9 | 2023 | 17 | |
| 10 | 2021 | 14 | |
| 11 | 2019 | 14 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 10 | |
| 14 | 2024 | 10 | |
| 15 | 2023 | 8 | |
| 16 | 2024 | 8 | |
| 17 | 2024 | 8 | |
| 18 | 2017 | 8 | |
| 19 | 2021 | 7 | |
| 20 | 2024 | 6 |
About Yize Li
Yize Li is a scholar working on Molecular Biology, Cancer Research, Physiology, Cellular and Molecular Neuroscience and Oncology, having authored 49 papers that have together received 446 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (6 papers), Cancer-related molecular mechanisms research (6 papers), Anesthesia and Neurotoxicity Research (5 papers), MicroRNA in disease regulation (5 papers), Sleep and Wakefulness Research (5 papers), Intensive Care Unit Cognitive Disorders (4 papers), RNA modifications and cancer (4 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Cancer Research (121 citations), Complementary and alternative medicine (60 citations), Developmental Neuroscience (17 citations), Neurology (29 citations) and Molecular Biology (205 citations). Yize Li has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Hongmei Zhang, Wenchao Liu, Siqi Wang, Yunman Li, Tao Xi, Weirong Fang, Wenyuan Liu, Yonghao Yu, Ru‐Rong Ji and Guolin Wang. Their work appears in journals such as Advanced Healthcare Materials, ACS Nano, Frontiers in Oncology, Cell Reports Medicine and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.